Sylvester Comprehensive Cancer Center

Articles

Jaime Merchán, MD, Named Sylvester’s Translational and Clinical Oncology Research Program Co-Leader

February 21st 2023

Jaime Merchán, MD, is the new Translational and Clinical Oncology Research Program co-leader at Sylvester Comprehensive Cancer Center, part of UHealth – University of Miami Health System.

Powerful AI Algorithm Provides New Insights into Deadly Glioblastoma and Other Cancers

February 10th 2023

An international research group, led by scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, has developed a new machine learning algorithm that can combine large datasets from multiple sources to pinpoint kinases and potentially target them for treatment.

Sylvester Receives Approval to Build World-Class Myeloma Research Institute

January 18th 2023

With three years to go, C. Ola Landgren, MD, PhD, is on track to establish a “top three” U.S. myeloma program within five years, with the announcement of the new, dedicated Myeloma Research Institute within Sylvester Comprehensive Cancer Center.

Sylvester Researchers Focus on Understanding Role of H. pylori in Gastric Cancer

November 30th 2022

Helicobacter pylori infection is a major cause of gastric cancer, and researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have several projects underway to better understand the association and develop much-needed prevention and treatment.

Sylvester Grant Funds Early-Stage Prostate Cancer Study

October 7th 2022

Researchers are investigating ways to make immunotherapies more effective.

Sylvester Game Changer Vehicle Among First in Nation to Offer Mobile Prostate Cancer Screening

September 27th 2022

Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine’s Game Changer vehicles, which bring health education and free screenings for many cancer types to South Florida communities in need, are offering prostate-specific antigen screening for prostate cancer.

Sylvester Expert Co-Authors Guidelines for Optimizing Cancer Survivor Nutrition and Physical Activity

September 7th 2022

More scientific evidence about the importance of nutrition and physical activity for cancer survivors has emerged in the past 10 years, prompting the American Cancer Society to update its guidance for physicians and patients.

Liver Cancer’s Changing Therapeutic Landscape

September 1st 2022

New treatments, particularly immunotherapies, are providing durable benefits for patients with hepatocellular carcinoma.

Sylvester Names Dr. Sophia George to Lead the Cancer Center’s Focus on Diversity, Equity, and Inclusion

August 26th 2022

Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine has named Sophia George, PhD, the inaugural associate director of diversity, equity, and inclusion.

Sylvester Researcher Leads Novel Pancreatic Cancer Study, Paving Way for Prestigious PanCAN Grant

August 19th 2022

Jashodeep Datta, MD, associate member of Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, led a study recently published in the journal Oncogene that helps to explain pancreatic cancer’s notorious virulence and resistance to therapy.

Sylvester Experts Explain the Most Promising Advances in Cancer Research and Treatment Presented at ASCO 2022

July 28th 2022

Cancer experts at the Sylvester Comprehensive Cancer Center: Annual Oncology Update shared important progress across a wide range of cancers — prostate cancer, breast cancer, colon cancer, and more — that was presented at the American Society of Clinical Oncology 2022 Annual Meeting, the largest gathering of cancer clinicians and scientists in the United States.

Sylvester Researchers Uncover New Cellular Oxygen-Sensing Pathway

June 27th 2022

A team of researchers with Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine has identified a new cellular oxygen-sensing pathway – a discovery that could potentially lead to new approaches for treating cancer and other diseases.

Sylvester Announces Transformational Cancer Research Building

June 23rd 2022

Sylvester Comprehensive Cancer Center is making another bold move to accelerate cancer research, celebrating the groundbreaking for a 244,000-square-foot, state-of-the-art Sylvester Comprehensive Cancer Center - Transformational Cancer Research Building.

New Research Highlights Racial Disparities in Genomic Profiling

May 23rd 2022

A new study by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine has found that Black women with metastatic breast cancer were less likely to have tumors with treatable genetic variations than white and Asian women.

Sylvester Researcher Receives Two Grants to Pursue Pediatric Immunotherapies

May 5th 2022

The Pillai lab will explore off-the-shelf, innate natural killer T cell immunotherapies that can be targeted against challenging tumors.

Renowned Robotic Surgeon First to Use New 3D Kidney Model

April 29th 2022

Renowned robotic urologic oncology surgeon Dipen J. Parekh, MD, was the first in the nation to test a new preoperative surgical rehearsal technology recently approved by the FDA for all genitourinary conditions.

Sylvester Joins Forces with College of Engineering to Cure Cancer

April 11th 2022

Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have joined forces with the University of Miami College of Engineering for a collaborative initiative to develop and deploy innovative technologies for early detection, diagnosis, and treatment of cancer.

Dr. Dorothy Graves Joins Sylvester as Assistant Vice President and Associate Director for Administration

March 21st 2022

Dorothy Graves, PhD, said she admired Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine years prior to being appointed Sylvester’s assistant vice president and associate director for administration in early 2022.

Bristol Myers Squibb Foundation Selects and Funds Sylvester Researcher for Its Diversity in Clinical Trials Career Development Program

March 2nd 2022

The Bristol Myers Squibb Foundation and National Medical Fellowships have selected Sylvester Comprehensive Cancer Center researcher Kristin E. Rojas, MD, FACS, for its inaugural Diversity in Clinical Trials Career Development Program.